|
TARDBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.228400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.240600E-01 |
| Normal-vs-Stage2 |
3.819800E-01 |
| Normal-vs-Stage3 |
5.708600E-01 |
| Normal-vs-Stage4 |
8.981800E-01 |
| Stage1-vs-Stage2 |
7.413600E-01 |
| Stage1-vs-Stage3 |
7.656200E-01 |
| Stage1-vs-Stage4 |
6.359000E-01 |
| Stage2-vs-Stage3 |
6.530000E-01 |
| Stage2-vs-Stage4 |
5.979200E-01 |
| Stage3-vs-Stage4 |
7.983600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.343400E-01 |
| Normal-vs-AfricanAmerican |
4.316000E-01 |
| Normal-vs-Asian |
4.471600E-01 |
| Caucasian-vs-AfricanAmerican |
8.703600E-01 |
| Caucasian-vs-Asian |
7.788400E-01 |
| AfricanAmerican-vs-Asian |
8.096800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.691810E-01 |
| Normal-vs-Female |
4.775000E-01 |
| Male-vs-Female |
1.848500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.927650E-01 |
| Normal-vs-Extreme_Weight |
9.435800E-02 |
| Normal-vs-Obese |
6.330400E-01 |
| Normal-vs-Extreme_Obese |
8.904300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.763600E-01 |
| Normal_Weight-vs-Obese |
8.933700E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.134600E-01 |
| Extreme_Weight-vs-Obese |
3.350400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.655800E-01 |
| Obese-vs-Extreme_Obese |
1.006000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.558000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.555600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.177570E-01 |
| Normal-vs-Age(81-100Yrs) |
2.563800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.744800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.679900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.401900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.433800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.608400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.645800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.536600E-01 |
| Normal-VS-Type2 PRCC |
1.199710E-03 |
| Normal-VS-KIRP CIMP |
3.804200E-03 |
| Normal-VS-Unclassified PRCC |
4.396200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.48610000000527E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.348450E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.788400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.80960000004416E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
3.944400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.297900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.895900E-03 |
| Normal-vs-N1 |
1.274420E-01 |
| Normal-vs-N2 |
7.163600E-01 |
| N0-vs-N1 |
9.92539999999931E-05 |
| N0-vs-N2 |
3.907000E-01 |
| N1-vs-N2 |
3.268600E-01 |
|
|
